N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide

C156H164N26O12S — CID 159890638

IUPACN-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide
SMILESCC(=O)CCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CC(=O)NCCCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CC(=O)NCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(C2=NCc3ccc(NC(=O)Cc4cccs4)cc32)cc1
InChIInChI=1S/C25H25N3O2S.C21H24N4O2.C19H20N4O2.C19H19N3O2.4C18H19N3O/c1-2-3-12-26-25(30)18-8-6-17(7-9-18)24-22-14-20(11-10-19(22)16-27-24)28-23(29)15-21-5-4-13-31-21;1-15(26)22-13-5-2-6-14-23-21(27)17-11-9-16(10-12-17)20-18-7-3-4-8-19(18)24-25-20;1-13(24)20-11-4-12-21-19(25)15-9-7-14(8-10-15)18-16-5-2-3-6-17(16)22-23-18;1-13(23)5-4-12-20-19(24)15-10-8-14(9-11-15)18-16-6-2-3-7-17(16)21-22-18;4*1-2-3-12-19-18(22)14-10-8-13(9-11-14)17-15-6-4-5-7-16(15)20-21-17/h4-11,13-14H,2-3,12,15-16H2,1H3,(H,26,30)(H,28,29);3-4,7-12H,2,5-6,13-14H2,1H3,(H,22,26)(H,23,27)(H,24,25);2-3,5-10H,4,11-12H2,1H3,(H,20,24)(H,21,25)(H,22,23);2-3,6-11H,4-5,12H2,1H3,(H,20,24)(H,21,22);4*4-11H,2-3,12H2,1H3,(H,19,22)(H,20,21)
InChIKeyNUSADVTUWKWZPA-UHFFFAOYSA-N
MW2627.26 g/mol
LogP28.93
Rot. Bonds48

About N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide

N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide (PubChem CID 159890638) has the molecular formula C156H164N26O12S and a molecular weight of 2627.26 g/mol. Its IUPAC name is N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide.

Molecular Properties

Compound NameN-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide
PubChem CID159890638
Molecular FormulaC156H164N26O12S
Molecular Weight2627.26 g/mol
Exact Mass2625.27
IUPAC NameN-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide
SMILESCC(=O)CCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CC(=O)NCCCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CC(=O)NCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(C2=NCc3ccc(NC(=O)Cc4cccs4)cc32)cc1
InChIInChI=1S/C25H25N3O2S.C21H24N4O2.C19H20N4O2.C19H19N3O2.4C18H19N3O/c1-2-3-12-26-25(30)18-8-6-17(7-9-18)24-22-14-20(11-10-19(22)16-27-24)28-23(29)15-21-5-4-13-31-21;1-15(26)22-13-5-2-6-14-23-21(27)17-11-9-16(10-12-17)20-18-7-3-4-8-19(18)24-25-20;1-13(24)20-11-4-12-21-19(25)15-9-7-14(8-10-15)18-16-5-2-3-6-17(16)22-23-18;1-13(23)5-4-12-20-19(24)15-10-8-14(9-11-15)18-16-6-2-3-7-17(16)21-22-18;4*1-2-3-12-19-18(22)14-10-8-13(9-11-14)17-15-6-4-5-7-16(15)20-21-17/h4-11,13-14H,2-3,12,15-16H2,1H3,(H,26,30)(H,28,29);3-4,7-12H,2,5-6,13-14H2,1H3,(H,22,26)(H,23,27)(H,24,25);2-3,5-10H,4,11-12H2,1H3,(H,20,24)(H,21,25)(H,22,23);2-3,6-11H,4-5,12H2,1H3,(H,20,24)(H,21,22);4*4-11H,2-3,12H2,1H3,(H,19,22)(H,20,21)
InChIKeyNUSADVTUWKWZPA-UHFFFAOYSA-N
XLogP28.93
TPSA550.29 Ų
H-Bond Donors18
H-Bond Acceptors21
Rotatable Bonds48
Heavy Atoms195
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002627.26
LogP ≤ 528.93
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[5-[(3R)-3-aminopyrrolidine-1-carbonyl]-2-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-3-methylthiophene-2-carboxamide
CID 56847653
N-[2-[(E)-2-(1H-indazol-3-yl)ethenyl]-5-(propylcarbamoyl)phenyl]-3-methylthiophene-2-carboxamide
CID 56847654
N-[2-[(E)-2-(1H-indazol-3-yl)ethenyl]-5-[3-(methylamino)pyrrolidine-1-carbonyl]phenyl]-3-methylthiophene-2-carboxamide
CID 68996671
N-[2-[2-(1H-indazol-3-yl)ethenyl]-5-[3-(methylamino)pyrrolidine-1-carbonyl]phenyl]-3-methylthiophene-2-carboxamide
CID 68996676
N-[5-(3-aminopyrrolidine-1-carbonyl)-2-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-3-methylthiophene-2-carboxamide
CID 68997003
N-[5-(3-aminopyrrolidine-1-carbonyl)-2-[2-(1H-indazol-3-yl)ethenyl]phenyl]-3-methylthiophene-2-carboxamide
CID 68997005
N-[5-[(3R)-3-aminopyrrolidine-1-carbonyl]-2-[2-(1H-indazol-3-yl)ethenyl]phenyl]-3-methylthiophene-2-carboxamide
CID 68997006
N-[2-[2-(1H-indazol-3-yl)ethenyl]-5-(propylcarbamoyl)phenyl]-3-methylthiophene-2-carboxamide
CID 69000663
N-[2-[(E)-2-(1H-indazol-3-yl)ethenyl]-5-(pyrrolidine-1-carbonyl)phenyl]-3-methylthiophene-2-carboxamide
CID 69002089
N-[2-[2-(1H-indazol-3-yl)ethenyl]-5-(pyrrolidine-1-carbonyl)phenyl]-3-methylthiophene-2-carboxamide
CID 69002092
N-[2-[[6-methyl-3-[2-[3-[(4-methylpiperazin-1-yl)methyl]phenyl]ethenyl]-1H-indazol-5-yl]amino]-2-oxo-1-thiophen-2-ylethyl]-N-[6-methyl-3-[2-[3-(morpholin-4-ylmethyl)phenyl]ethenyl]-1H-indazol-5-yl]-3-[2-[6-methyl-5-[(2-thiophen-2-ylacetyl)amino]-1H-indazol-3-yl]ethenyl]-2-thiophen-2-ylbenzamide
CID 87873696
6-[4-[(5-bromothiophene-2-carbonyl)amino]phenyl]-N-methyl-1H-indazole-3-carboxamide
CID 157177845

Frequently Asked Questions

What is the IUPAC name of N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide?
The IUPAC name of N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide (CID 159890638) is N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide.
What is the SMILES notation for N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide?
The canonical SMILES for N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide is CC(=O)CCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CC(=O)NCCCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CC(=O)NCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1.CCCCNC(=O)c1ccc(C2=NCc3ccc(NC(=O)Cc4cccs4)cc32)cc1.
What is the InChIKey of N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide?
The InChIKey is NUSADVTUWKWZPA-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H25N3O2S.C21H24N4O2.C19H20N4O2.C19H19N3O2.4C18H19N3O/c1-2-3-12-26-25(30)18-8-6-17(7-9-18)24-22-14-20(11-10-19(22)16-27-24)28-23(29)15-21-5-4-13-31-21;1-15(26)22-13-5-2-6-14-23-21(27)17-11-9-16(10-12-17)20-18-7-3-4-8-19(18)24-25-20;1-13(24)20-11-4-12-21-19(25)15-9-7-14(8-10-15)18-16-5-2-3-6-17(16)22-23-18;1-13(23)5-4-12-20-19(24)15-10-8-14(9-11-15)18-16-6-2-3-7-17(16)21-22-18;4*1-2-3-12-19-18(22)14-10-8-13(9-11-14)17-15-6-4-5-7-16(15)20-21-17/h4-11,13-14H,2-3,12,15-16H2,1H3,(H,26,30)(H,28,29);3-4,7-12H,2,5-6,13-14H2,1H3,(H,22,26)(H,23,27)(H,24,25);2-3,5-10H,4,11-12H2,1H3,(H,20,24)(H,21,25)(H,22,23);2-3,6-11H,4-5,12H2,1H3,(H,20,24)(H,21,22);4*4-11H,2-3,12H2,1H3,(H,19,22)(H,20,21).
What are the key properties of N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide?
N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide has a molecular weight of 2627.26 g/mol, XLogP of 28.93, 48 rotatable bonds, 18 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-acetamidopentyl)-4-(1H-indazol-3-yl)benzamide;N-(3-acetamidopropyl)-4-(1H-indazol-3-yl)benzamide;tetrakis(N-butyl-4-(1H-indazol-3-yl)benzamide);N-butyl-4-[6-[(2-thiophen-2-ylacetyl)amino]-3H-isoindol-1-yl]benzamide;4-(1H-indazol-3-yl)-N-(4-oxopentyl)benzamide is sourced from PubChem (CID 159890638), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).